FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+12.48%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$20.1B
AUM Growth
+$1.71B
(+9.3%)
Cap. Flow
-$141M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
38.54%
Holding
575
New
91
Increased
134
Reduced
234
Closed
49
Top Buys
| 1 |
Walt Disney
DIS
|
$221M |
| 2 |
Apple
AAPL
|
$146M |
| 3 |
Microchip Technology
MCHP
|
$137M |
| 4 |
T-Mobile US
TMUS
|
$126M |
| 5 |
Cognizant
CTSH
|
$122M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$391M |
| 2 |
NXP Semiconductors
NXPI
|
$168M |
| 3 |
Newell Brands
NWL
|
$163M |
| 4 |
Electronic Arts
EA
|
$147M |
| 5 |
Biogen
BIIB
|
$143M |
Sector Composition
| 1 | Technology | 25.01% |
| 2 | Communication Services | 18.63% |
| 3 | Healthcare | 14.3% |
| 4 | Consumer Discretionary | 12.48% |
| 5 | Financials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
351
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $605K | ﹤0.01% |
5,000
+500
| +11% | +$60.5K |
|
352
Credicorp
BAP
$20.7B
| $601K | ﹤0.01% |
3,680
+1,480
| +67% | +$242K |
|
|
GBT
353
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $590K | ﹤0.01% |
16,000
+4,000
| +33% | +$148K |
|
354
West Pharmaceutical
WST
$18B
| $571K | ﹤0.01% |
7,000
-1,250
| -15% | -$102K |
|
|
SAGE
355
DELISTED
Sage Therapeutics
SAGE
| $569K | ﹤0.01% |
+8,000
| New | +$569K |
|
|
KITE
356
DELISTED
Kite Pharma, Inc.
KITE
| $549K | ﹤0.01% |
+7,000
| New | +$549K |
|
357
Adecoagro
AGRO
$829M
| $525K | ﹤0.01% |
45,778
-12,815
| -22% | -$147K |
|
|
TTM
358
DELISTED
Tata Motors Limited
TTM
| $506K | ﹤0.01% |
14,200
-2,410
| -15% | -$85.9K |
|
359
Supernus Pharmaceuticals
SUPN
$2.58B
| $501K | ﹤0.01% |
16,000
+6,000
| +60% | +$188K |
|
|
HIND
360
Vyome Holdings, Inc. Common Stock
HIND
$210M
| – | – |
0
| – | -$414K |
|
361
Amicus Therapeutics
FOLD
$2.46B
| $499K | ﹤0.01% |
70,000
+10,000
| +17% | +$71.3K |
|
362
Trimble
TRMB
$19.2B
| $472K | ﹤0.01% |
14,753
-20,213
| -58% | -$647K |
|
363
Chevron
CVX
$310B
| $450K | ﹤0.01% |
4,190
-500
| -11% | -$53.7K |
|
|
CVA
364
DELISTED
Covanta Holding Corporation
CVA
| $437K | ﹤0.01% |
27,828
-4,747
| -15% | -$74.5K |
|
|
FPRX
365
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $434K | ﹤0.01% |
12,000
-3,000
| -20% | -$109K |
|
|
DBVT
366
DBV Technologies
DBVT
$245M
| $428K | ﹤0.01% |
1,215
| – | – |
|
367
Grupo Aeroportuario del Sureste
ASR
$10.2B
| $411K | ﹤0.01% |
+2,370
| New | +$411K |
|
368
New Oriental
EDU
$7.98B
| $400K | ﹤0.01% |
6,618
-3,207
| -33% | -$194K |
|
|
RARX
369
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $383K | ﹤0.01% |
18,000
+3,346
| +23% | +$71.2K |
|
370
HCA Healthcare
HCA
$98.5B
| $375K | ﹤0.01% |
4,215
-725
| -15% | -$64.5K |
|
371
GeoPark
GPRK
$326M
| $372K | ﹤0.01% |
+51,987
| New | +$372K |
|
372
Xylem
XYL
$34.2B
| $337K | ﹤0.01% |
6,701
-11,337
| -63% | -$570K |
|
373
Woodward
WWD
$14.6B
| $326K | ﹤0.01% |
4,802
-3,434
| -42% | -$233K |
|
374
Aecom
ACM
$16.8B
| $320K | ﹤0.01% |
8,997
-5,588
| -38% | -$199K |
|
375
Medpace
MEDP
$13.7B
| $315K | ﹤0.01% |
+10,564
| New | +$315K |
|